Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SUN13837 for acute stroke has been withdrawn. No efficacy, safety, tolerability or pharmacokinetic results are reported for this indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SUN13837

Snippet

Sponsor: Daiichi Sankyo | Conditions: Stroke | Phase 2 | Status: WITHDRAWN